Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Che-1/miR-590-3p/TAZ axis sustains multiple myeloma disease.
Bruno T, Catena V, Corleone G, Cortile C, Cappelletto MC, Bellei B, De Nicola F, Amadio B, Gumenyuk S, Marchesi F, Annibali O, Blandino G, Fanciulli M, Di Agostino S. Bruno T, et al. Among authors: gumenyuk s. Leukemia. 2024 Apr;38(4):877-882. doi: 10.1038/s41375-024-02168-z. Epub 2024 Feb 17. Leukemia. 2024. PMID: 38368441 Free PMC article. No abstract available.
Che-1/AATF-induced transcriptionally active chromatin promotes cell proliferation in multiple myeloma.
Bruno T, De Nicola F, Corleone G, Catena V, Goeman F, Pallocca M, Sorino C, Bossi G, Amadio B, Cigliana G, Ricciardi MR, Petrucci MT, Spugnini EP, Baldi A, Cioce M, Cortese G, Mattei E, Merola R, Gianelli U, Baldini L, Pisani F, Gumenyuk S, Mengarelli A, Höpker K, Benzing T, Vincenzi B, Floridi A, Passananti C, Blandino G, Iezzi S, Fanciulli M. Bruno T, et al. Among authors: gumenyuk s. Blood Adv. 2020 Nov 24;4(22):5616-5630. doi: 10.1182/bloodadvances.2020002566. Blood Adv. 2020. PMID: 33186461 Free PMC article.
The predictive value of Aspergillus PCR testing on bronchoalveolar lavage fluid for early diagnosis of invasive pulmonary aspergillosis in hematologic patients.
Marchesi F, Spadea A, Pimpinelli F, Prignano G, Paglia MG, Forcella D, Gumenyuk S, Renzi D, Palombi F, Vulcano A, Pisani F, Romano A, Papa E, Facciolo F, Ensoli F, Girmenia C, Mengarelli A. Marchesi F, et al. Among authors: gumenyuk s. Leuk Lymphoma. 2017 Dec;58(12):2943-2946. doi: 10.1080/10428194.2017.1315116. Epub 2017 May 9. Leuk Lymphoma. 2017. PMID: 28482726 No abstract available.
Impact of anti-CD20 monoclonal antibodies on serologic response to BNT162b2 vaccine in B-cell Non-Hodgkin's lymphomas.
Marchesi F, Pimpinelli F, Giannarelli D, Ronchetti L, Papa E, Falcucci P, Pontone M, Di Domenico EG, di Martino S, Laquintana V, Mandoj C, Conti L, Cordone I, La Malfa A, Viggiani C, Renzi D, Palombi F, Romano A, Pisani F, Gumenyuk S, Di Bella O, Vujovic B, Morrone A, Ciliberto G, Ensoli F, Mengarelli A. Marchesi F, et al. Among authors: gumenyuk s. Leukemia. 2022 Feb;36(2):588-590. doi: 10.1038/s41375-021-01418-8. Epub 2021 Sep 20. Leukemia. 2022. PMID: 34545184 Free PMC article. No abstract available.
Biosimilar filgrastim (Zarzio®) vs. lenograstim (Myelostim®) for peripheral blood stem cell mobilization in adult patients with lymphoma and myeloma: a single center experience.
Marchesi F, Vacca M, Gumenyuk S, Pandolfi A, Renzi D, Palombi F, Pisani F, Romano A, Spadea A, Ipsevich F, Santinelli S, De Rienzo M, Papa E, Canfora M, Laurenzi L, Foddai ML, Pierelli L, Mengarelli A. Marchesi F, et al. Among authors: gumenyuk s. Leuk Lymphoma. 2016 Feb;57(2):489-492. doi: 10.3109/10428194.2015.1063147. Epub 2015 Jul 18. Leuk Lymphoma. 2016. PMID: 26099572 No abstract available.
Comparison between biosimilar filgrastim vs other granulocyte-colony stimulating factor formulations (originator filgrastim, peg-filgrastim and lenograstim) after autologous stem cell transplantation: a retrospective survey from the Rome Transplant Network.
Marchesi F, Cerchiara E, Dessanti ML, Gumenyuk S, Franceschini L, Palombi F, Pisani F, Romano A, Spadea A, Pupo L, Annibali O, La Malfa A, Arcese W, Mengarelli A. Marchesi F, et al. Among authors: gumenyuk s. Br J Haematol. 2015 Apr;169(2):293-6. doi: 10.1111/bjh.13199. Epub 2014 Nov 5. Br J Haematol. 2015. PMID: 25371286 Free article. No abstract available.
Prevention of Bortezomib-Induced Peripheral Neuropathy in Newly Multiple Myeloma Patients Using Nervonic Acid, Curcuma Rizoma, and L-Arginine Compound: A Pilot Study.
Maschio M, Maialetti A, Marchesi F, Gumenyuk S, Pisani F, Papa E, Galiè E, Koudriavtseva T, Graziano G, Giannarelli D, Mengarelli A. Maschio M, et al. Among authors: gumenyuk s. Integr Cancer Ther. 2022 Jan-Dec;21:15347354221114142. doi: 10.1177/15347354221114142. Integr Cancer Ther. 2022. PMID: 35866451 Free PMC article.
Prevention of Bortezomib-Related Peripheral Neuropathy With Docosahexaenoic Acid and α-Lipoic Acid in Patients With Multiple Myeloma: Preliminary Data.
Maschio M, Zarabla A, Maialetti A, Marchesi F, Giannarelli D, Gumenyuk S, Pisani F, Renzi D, Galiè E, Mengarelli A. Maschio M, et al. Among authors: gumenyuk s. Integr Cancer Ther. 2018 Dec;17(4):1115-1124. doi: 10.1177/1534735418803758. Epub 2018 Oct 8. Integr Cancer Ther. 2018. PMID: 30295079 Free PMC article.
36 results